QNCX Collar Strategy
QNCX (Quince Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport diverse therapeutic agents, such as small molecules, peptides, and large molecules, directly to affected bone areas like fractures and disease sites. Leading their pipeline is NOV004, an anabolic peptide meticulously designed to pinpoint and accumulate its therapeutic action precisely at bone fracture locations. The company, previously known as Cortexyme, Inc., officially rebranded as Quince Therapeutics, Inc. in August 2022. Established in 2012, Quince Therapeutics is headquartered in South San Francisco, California.
QNCX (Quince Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $9.5M, a beta of 1.40 versus the broader market, a 52-week range of 15.1-910, average daily share volume of 56K, a public-listing history dating back to 2019, approximately 38 full-time employees. These structural characteristics shape how QNCX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.40 indicates QNCX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a collar on QNCX?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
QNCX snapshot
As of August 14, 2026, spot at $31.50, ATM IV 377.80%, IV rank 75.90%, expected move 108.31%. The collar on QNCX below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.
Why this collar structure on QNCX specifically: IV regime affects collar pricing on both sides; elevated QNCX IV at 377.80% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 108.31% (roughly $34.12 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated QNCX expiries trade a higher absolute premium for lower per-day decay. Position sizing on QNCX should anchor to the underlying notional of $31.50 per share and to the trader's directional view on QNCX stock.
QNCX collar setup
The QNCX collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With QNCX at $31.50 on that close, the first option leg uses a $33.08 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed QNCX chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 QNCX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $31.50 | long |
| Sell 1 | Call | $33.08 | N/A |
| Buy 1 | Put | $29.92 | N/A |
QNCX collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
QNCX collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on QNCX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on QNCX
Collars on QNCX hedge an existing long QNCX stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
QNCX thesis for this collar
The market-implied 1-standard-deviation range for QNCX extends from approximately $-2.62 on the downside to $65.62 on the upside. A QNCX collar hedges an existing long QNCX position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current QNCX IV rank near 75.90% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on QNCX at 377.80%. As a Healthcare name, QNCX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to QNCX-specific events.
QNCX collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. QNCX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move QNCX alongside the broader basket even when QNCX-specific fundamentals are unchanged. Always rebuild the position from current QNCX chain quotes before placing a trade.
Frequently asked questions
- What is a collar on QNCX?
- A collar on QNCX is the collar strategy applied to QNCX (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With QNCX stock at $31.50 on the most recent close, the strikes shown on this page are snapped to the nearest listed QNCX chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are QNCX collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the QNCX collar priced from the end-of-day chain at a 30-day expiry (ATM IV 377.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a QNCX collar?
- The breakeven for the QNCX collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The QNCX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 108.31%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on QNCX?
- Collars on QNCX hedge an existing long QNCX stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current QNCX implied volatility affect this collar?
- QNCX ATM IV is at 377.80% with IV rank near 75.90%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.